The Arkansas Department of Health (ADH) is issuing a public health advisory to warn Arkansans about the risks of harm associated with use of products derived from cannabis, including marijuana and hemp, that claim to benefit health. ADH is partnering with Arkansas Surgeon General Dr. Greg Bledsoe and Arkansas Drug Director Kirk Lane in urging Arkansans to be aware of the risks associated with these products.
To see the advisory, go to www.healthy.arkansas.gov. Among the risks cited in the new ADH Public Health and Safety Advisory are:
-Marijuana is addictive. Approximately one in 11 adults who use marijuana will become addicted, and the risk of addiction is greater among youth.
-Marijuana now available is more potent with higher levels of tetrahydrocannabinol, or THC, the primary psychoactive substance in cannabis than marijuana available in previous decades. The long-term health or developmental consequences of exposure to these high concentrations of THC are unknown.
-Marijuana use is associated with adverse health outcomes including development of psychoses like schizophrenia and increased risk of motor vehicle crashes.
-Marijuana is particularly harmful to a developing child. Smoking marijuana during pregnancy is associated with being born at low birth weight, a risk factor for death in the child’s first year of life.
-There are a limited number of conditions where there is substantial or conclusive evidence for using cannabis-derived products as medication, but outside of these conditions, there is not sufficient evidence to show that any form of cannabis, including marijuana or hemp, is safe and effective as medication.
-Due to a lack of regulations on products containing cannabidiol (CBD), consumers cannot be certain what they will receive if purchasing a product purported to contain CBD.
-Marijuana impairs judgment and can lead to actions that result in injury or death.